These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30136085)

  • 21. A comparative study on several models of experimental renal calcium oxalate stones formation in rats.
    Liu J; Cao Z; Zhang Z; Zhou S; Ye Z
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):83-7. PubMed ID: 17393118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and management of non-calcium-containing stones in the pediatric population.
    Ranabothu S; Bernstein AP; Drzewiecki BA
    Int Urol Nephrol; 2018 Jul; 50(7):1191-1198. PubMed ID: 29846891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vitamin D and urinary stone disease: the current state of problem].
    Ali HM; Saenko VS; Pesegov SV; Ali SH; Vovdenko SV; Kazilov YB
    Urologiia; 2018 Dec; (5):122-127. PubMed ID: 30575362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monocyte Mitochondrial Function in Calcium Oxalate Stone Formers.
    Williams J; Holmes RP; Assimos DG; Mitchell T
    Urology; 2016 Jul; 93():224.e1-6. PubMed ID: 26972146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The renal sensitivity for endogenous parathormone in patients with primary hyperparathyroidism, vitamin D deficiency and renal stones.
    vd Velden PC; Fischer HR; Schopman W; van Roon F; Koorevaar G; Hackeng WH; Silberbusch J
    Horm Metab Res; 1986 Jul; 18(7):485-9. PubMed ID: 3017831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteopontin and calcium stone formation.
    Kleinman JG; Wesson JA; Hughes J
    Nephron Physiol; 2004; 98(2):p43-7. PubMed ID: 15499214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic risk factors in patients with first-time and recurrent stone formations as determined by comprehensive metabolic evaluation.
    Yagisawa T; Chandhoke PS; Fan J
    Urology; 1998 Nov; 52(5):750-5. PubMed ID: 9801093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Metabolic effects of Cholecalciferol supplementation in kidney stone formers with vitamin D deficiency].
    Vitale C; Tricerri A; Bermond F; Fabbrini L; Guiotto C; Marangella M
    G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic evidence of calculus attachment to Randall's plaque.
    Matlaga BR; Williams JC; Kim SC; Kuo RL; Evan AP; Bledsoe SB; Coe FL; Worcester EM; Munch LC; Lingeman JE
    J Urol; 2006 May; 175(5):1720-4; discussion 1724. PubMed ID: 16600740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low molecular weight urinary proteins and renal lithiasis.
    Resnick MI; Boyce WH
    Invest Urol; 1979 Jan; 16(4):270-3. PubMed ID: 429118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observations on calcium oxalate stone formers.
    el-Sharabasy MM
    Br J Urol; 1992 Nov; 70(5):474-7. PubMed ID: 1361403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers.
    Pasch A; Frey FJ; Eisenberger U; Mohaupt MG; Bonny O
    Nephrol Dial Transplant; 2008 Aug; 23(8):2563-70. PubMed ID: 18398019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No contribution of ascorbic acid to renal calcium oxalate stones.
    Gerster H
    Ann Nutr Metab; 1997; 41(5):269-82. PubMed ID: 9429689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity and urolithiasis: evidence of regional influences.
    Trinchieri A; Croppi E; Montanari E
    Urolithiasis; 2017 Jun; 45(3):271-278. PubMed ID: 27488444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium stone disease: a multiform reality.
    Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythrocyte oxidative stress in patients with calcium oxalate stones correlates with stone size and renal tubular damage.
    Ma MC; Chen YS; Huang HS
    Urology; 2014 Feb; 83(2):510.e9-17. PubMed ID: 24360074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interconversion of stone composition profiles from two recurrent stone episodes in stone formers.
    Zeng G; Zhao Z; Wu W; Ou L; Liang Y; Yuan J
    Clin Chem Lab Med; 2014 Jul; 52(7):1019-24. PubMed ID: 24633751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.